Drug profile · INN
spheroids of human autologous matrix-associated chondrocytes
SPHEROX
spheroids of human autologous matrix-associated chondrocytes (SPHEROX) is a somatic cell supplemental therapy.
EMA: approved Musculo-skeletal system (M09) M09AX02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — spheroids of human autologous matrix-associated chondrocytes
- Class
- Musculo-skeletal system (M09)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
spheroids of human autologous matrix-associated chondrocytes (SPHEROX) is a somatic cell supplemental therapy.
Key facts
INN spheroids of human autologous matrix-associated chondrocytes
Brand SPHEROX
Mechanism Somatic cell supplemental therapy
Therapeutic class Musculo-skeletal system (M09)
ATC code M09AX02
Mechanism of action
Somatic cell supplemental therapy
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is spheroids of human autologous matrix-associated chondrocytes?
spheroids of human autologous matrix-associated chondrocytes (SPHEROX) is a somatic cell supplemental therapy.
What is the brand name for spheroids of human autologous matrix-associated chondrocytes?
SPHEROX is a marketed brand name for spheroids of human autologous matrix-associated chondrocytes. Check FDA Drugs@FDA for the current US label holder and prescribing information.